In the present study, we found that the imbalance of the NTN‐1/DCC pathway is a common feature of dopaminergic neurodegeneration and, for the first time, revealed that plasma NTN‐1 levels were significantly lower in PD patients than in aged‐matched HC. This evidence concerns the gene NTN1 and Parkinson disease.